Circassia Pharmaceuticals (CSSPF) Price & Analysis

Compare

8 Followers

CSSPF Stock Chart & Stats

$0.90

$0.00(0.00%)

At close: Jul 03 4:00 PM EDT

$0.90

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.00 - $93.32

Previous CloseN/A

Volume60.00K

Average Volume (3M)0.00

Market Cap

£364.47M

Enterprise Value$278.94M

Total Cash (Recent Filing)£11.80M

Total Debt (Recent Filing)£1.20M

Price to Earnings (P/E)53.5

Beta1.46

Next Earnings

Mar 24, 2026

EPS EstimateN/A

Last Dividend Ex-Date

May 16, 2025

Dividend Yield1.81%

Share Statistics

EPS (TTM)0.02

Shares OutstandingN/A

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio-1.09

Price to Book (P/B)4.43

Price to Sales (P/S)6.30

P/FCF Ratio16.26

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusHold

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Acquisition InterestNIOX has announced it has received a possible 81p/share all-cash offer from Keensight Capital valuing the business at £322m.

Market CompetitionThere also appear to be other counterparties considering an offer for the business so competing bids may yet emerge.

Shareholder ValueThe offer represents good value for shareholders for a single-product business in this space.

Bears Say

Acquisition UncertaintyDiscussions are early stages with no formal offer as yet from Keensight.

Macroeconomic EnvironmentKeensight Capital has announced that it does not intend to make a firm offer for the business at this stage due to the current uncertain macroeconomic environment.

Share Price VolatilityA level of weakness in the share price is anticipated due to recent newsflow and share price action related to it.

Circassia Pharmaceuticals News

NIOX Group Updates Total Voting Rights Following Share Option Exercises

Circassia Pharmaceuticals ( ($GB:NIOX) ) has shared an announcement. NIOX Group plc announced an update on its total...

12d ago

NIOX Group Announces Total Voting Rights and Share Option Exercise

Circassia Pharmaceuticals ( ($GB:NIOX) ) has issued an update. NIOX Group plc, a company listed on the AIM...

1M ago

NIOX Group Reports Strong H1 2025 Financial Results Amid Global Expansion

An update from Circassia Pharmaceuticals ( ($GB:NIOX) ) is now available. NIOX Group PLC reported a strong financial...

1M ago

NIOX Group Updates Total Voting Rights After Share Option Exercise

Circassia Pharmaceuticals ( ($GB:NIOX) ) just unveiled an announcement. NIOX Group plc, a company listed on the AIM...

2M ago

NIOX Group Updates Total Voting Rights Following Employee Share Option Exercise

Circassia Pharmaceuticals ( ($GB:NIOX) ) has shared an update. NIOX Group plc, a company listed on the AIM...

3M ago

NIOX Group CEO’s Associate Increases Shareholding

The latest announcement is out from Circassia Pharmaceuticals ( ($GB:NIOX) ). NIOX Group plc, a company listed on...

4M ago

NIOX Group Reports Strong H1 2025 Performance Amid Strategic Focus

Circassia Pharmaceuticals ( ($GB:NIOX) ) just unveiled an announcement. NIOX Group plc reported a robust performance for the...

4M ago

NIOX Group Issues New Shares to Non-Executive Chairman

Circassia Pharmaceuticals ( ($GB:NIOX) ) has shared an update. NIOX Group plc, a company listed on AIM, has...

5M ago

Rathbones Increases Stake in Niox Group PLC

Circassia Pharmaceuticals ( ($GB:NIOX) ) has issued an announcement. Niox Group PLC, a UK-based issuer, has experienced a...

5M ago

Niox Group PLC Shareholder Update: Rathbones Adjusts Voting Rights

Circassia Pharmaceuticals ( ($GB:NIOX) ) has shared an announcement. Niox Group PLC, a UK-based company, has announced a...

5M ago

Niox Group upgraded to Buy from Hold at Panmure Liberum

Panmure Liberum upgraded Niox Group (CSSPF) to Buy from Hold with a 69 GBp price target Published first...

10M ago

Circassia Group initiated with a Hold at Deutsche Bank

Deutsche Bank initiated coverage of Circassia Group with a Hold rating and 250 GBp price target. The analyst...

2y ago

CSSPF FAQ

What was Circassia Pharmaceuticals PLC’s price range in the past 12 months?

Circassia Pharmaceuticals PLC lowest stock price was $0.00 and its highest was $93.32 in the past 12 months.

What is Circassia Pharmaceuticals PLC’s market cap?

Circassia Pharmaceuticals PLC’s market cap is £364.47M.

When is Circassia Pharmaceuticals PLC’s upcoming earnings report date?

Circassia Pharmaceuticals PLC’s upcoming earnings report date is Mar 24, 2026 which is in 132 days.

How were Circassia Pharmaceuticals PLC’s earnings last quarter?

Circassia Pharmaceuticals PLC released its earnings results on Sep 30, 2025. The company reported $0.019 earnings per share for the quarter, beating the consensus estimate of N/A by $0.019.

Is Circassia Pharmaceuticals PLC overvalued?

According to Wall Street analysts Circassia Pharmaceuticals PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Circassia Pharmaceuticals PLC pay dividends?

Circassia Pharmaceuticals PLC pays a Annually dividend of $0.017 which represents an annual dividend yield of 1.81%. See more information on Circassia Pharmaceuticals PLC dividends here

What is Circassia Pharmaceuticals PLC’s EPS estimate?

Circassia Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Circassia Pharmaceuticals PLC have?

Currently, no data Available

What happened to Circassia Pharmaceuticals PLC’s price movement after its last earnings report?

Circassia Pharmaceuticals PLC reported an EPS of $0.019 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.012%.

Which hedge fund is a major shareholder of Circassia Pharmaceuticals PLC?

Currently, no hedge funds are holding shares in CSSPF

Circassia Pharmaceuticals Stock Smart Score

Neutral

Analyst Consensus

Hold

Average Price Target:
― (―)

Technicals

Fundamentals

Return on Equity

6.70%

Trailing 12-Months

Asset Growth

-18.86%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Circassia Pharmaceuticals PLC

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.